Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia–(BUSINESS WIRE)–#antibodies–AbCellera Biologics Inc., a global leader in therapeutic antibody discovery from natural immune systems, today announced that…
Scynexis biotechnology company on Thursday announced positive top-line results for its Phase 3 VANISH-303 study investigating the safety and efficacy of oral ibrexafungerp as a treatment for women with vulvovaginal candidiasis (VVC).
LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global vaccines market and the market is poised to grow by USD 13.81 billion…
– Prominent PWS clinical expert along with company management will discuss disease epidemiology, current treatment landscape and livoletide as a…
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that the company is scheduled to participate in the Stephens 2019 Nashville…
–Prestigious Prize Conferred for GPCR Program Discoveries– SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today announced that three of its scientists––Alexander Gragerov,…
The TGen-sponsored clinical trial in recently-diagnosed ALS patients will integrate the Aural Analytics speech analytics platform technology DENVER & SCOTTSDALE,…
— Partnership with the Boston-based R&D innovation unit of LEO Pharma A/S advances development of Epicore Biosystems’ wearable Discovery patch…
CEO Patrick Jordan and other biopharmaceutical leaders to discuss industry’s shifting focus on women’s health at Europe’s largest life science…
Advanced its Phase 3 program for uproleselan in acute myeloid leukemia (AML) through both Company-sponsored and NCI-sponsored clinical trials Announced…